Revelation Biosciences Inc (REVB) Stock Price, Quote & News

Company Profile

Revelation Biosciences, Inc. operates as a clinical-stage biopharmaceutical company that focuses on the development and commercialization of immune system therapeutics and diagnostics. It engages in developing therapeutic product candidates, including GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease. The company was formerly known as Petra Acquisition, Inc. and changed...

Industry: Biotechnology

Sector: Healthcare

Phone: (650) 800-3717

Website: www.revbiosciences.com

Address:

4660 La Jolla Village Drive, Suite 100, San Diego, United States

TheOldGeezer Jun. 16 at 5:31 PM

$REVB Not sure if does any good impacting shorts but did a GTC + Extended at $3.98 - set it and forget it - just like a 4 way parley bet will be a 0 or 4 bagger - just playing until nfl season kicks off

0 · Reply

Luvtoretire Jun. 16 at 4:48 PM

$SRM —Nice going bulls! $REVB —Lower float. Under 900k.

0 · Reply

lookgoodplaygood22 Jun. 15 at 1:44 AM

$REVB 50,000 shares. Sell set at $3. Set it and forget it.

1 · Reply

Extrawing22 Jun. 14 at 11:50 PM

$REVB Results are scheduled to be released before summer. It's likely this the week. Accumulating

1 · Reply

Fundy101 Jun. 13 at 2:39 PM

$REVB

0 · Reply

hassan101 Jun. 13 at 2:25 PM

$REVB Be ready.👌

0 · Reply

Luvtoretire Jun. 13 at 12:04 PM

$HUSA —Well done bulls! With half the float; $REVB —

0 · Reply

OrangeJoolius Jun. 12 at 6:16 PM

$REVB Added, this will at minimum go to 2 bucks when the data releases. Will buy more every time shorts attack it for stop losses.

0 · Reply

Locogomez Jun. 12 at 5:57 PM

$REVB New lows incoming…

0 · Reply

thaboss8854 Jun. 12 at 5:52 PM

$REVB patiently waiting for the topline data that will make the stock prices reach the top line.

0 · Reply

Revelation Biosciences, Inc. Announces Closing of $4 Million Public Offering

May 29, 2025, 8:00 AM EDT - 18 days ago

Revelation Biosciences, Inc. Announces Pricing of $4 Million Public Offering

May 23, 2025, 4:05 PM EDT - 23 days ago

Revelation Biosciences Announces Retirement of George Tidmarsh, MD, PhD from Board of Directors

May 8, 2025, 4:15 PM EDT - 5 weeks ago

Revelation Biosciences, Inc. Announces Financial Results for the Three Months Ended March 31, 2025

Apr 29, 2025, 9:00 AM EDT - 6 weeks ago

Revelation Biosciences to Develop Gemini for Infection in Severe Burn Patients

Mar 17, 2025, 6:00 AM EDT - 3 months ago

Gemini Priming Attenuates Inflammation in Human Peripheral Blood Mononuclear Cells

Mar 13, 2025, 6:00 AM EDT - 3 months ago

Revelation Biosciences to Host Fireside Chat at 37th Annual Roth Conference

Mar 6, 2025, 4:15 PM EST - 3 months ago

Revelation Biosciences, Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2024

Feb 26, 2025, 6:00 AM EST - 3 months ago

Revelation Biosciences Doses First Patient in PRIME Phase 1b Clinical Study of Gemini in CKD Patients

Feb 24, 2025, 6:00 AM EST - 4 months ago

Revelation Biosciences, Inc. Receives Continued NASDAQ Listing Approval

Jan 24, 2025, 6:00 AM EST - 5 months ago

Revelation Biosciences Inc. Announces 1-for-16 Reverse Stock Split Effective January 28, 2025

Jan 21, 2025, 6:00 AM EST - 5 months ago

Revelation Biosciences Starts its PRIME Phase 1b Clinical Study of Gemini in CKD Patients

Jan 13, 2025, 6:00 AM EST - 5 months ago

Revelation Biosciences Inc. Reminds You to Vote for the Special Meeting on January 17, 2025

Jan 6, 2025, 6:00 AM EST - 5 months ago

Nasdaq Grants Revelation Biosciences Inc. Continued Listing

Dec 3, 2024, 8:38 AM EST - 6 months ago

Revelation Biosciences Inc. Announces Exercise of Warrants for $4 Million in Gross Proceeds

Dec 2, 2024, 6:00 AM EST - 7 months ago

Revelation Biosciences Inc. Announces FDA Acceptance of Gemini IND

Nov 12, 2024, 6:00 AM EST - 7 months ago

Revelation Biosciences, Inc. Completes the GMP Manufacture of Gemini Clinical Drug Supply

Nov 8, 2024, 4:15 PM EST - 7 months ago

Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2024

Sep 24, 2024, 6:00 AM EDT - 9 months ago

Revelation Biosciences' Gemini Induces Dose Dependent Significant Increases in IL-10

Aug 21, 2024, 5:30 PM EDT - 10 months ago

Revelation Biosciences Inc. Announces Exercise of Warrants for $3.8 Million in Gross Proceeds

Aug 9, 2024, 4:15 PM EDT - 11 months ago

Revelation Biosciences, Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2024

Jun 24, 2024, 9:00 AM EDT - 1 year ago

Revelation Biosciences Announces Phase 1 Clinical Study of Gemini Met the Primary Safety Endpoint and Showed Statistically Significant Biomarker Activity

Jun 13, 2024, 9:21 AM EDT - 1 year ago

Revelation Biosciences Has Completed Dosing of its First in Human Phase 1 Clinical Study of Gemini

May 10, 2024, 4:52 PM EDT - 1 year ago

Revelation Biosciences, Inc. Announces Financial Results for the Three Months Ended March 31, 2024

Mar 22, 2024, 4:15 PM EDT - 1 year ago

Revelation Biosciences, Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2023

Mar 13, 2024, 9:00 AM EDT - 1 year ago

Revelation Biosciences Inc. Gives Oral Presentation at Advances in Critical Care Nephrology (AKI & CRRT 2024)

Mar 12, 2024, 9:00 AM EDT - 1 year ago

Revelation Biosciences Inc. to Participate in a Virtual Fireside Chat at the 36th Annual Roth Conference

Mar 4, 2024, 9:00 AM EST - 1 year ago

Revelation Biosciences Inc. Announces Commencement of First in Human Phase 1 Clinical Study of Gemini

Feb 13, 2024, 9:00 AM EST - 1 year ago

Revelation Biosciences Inc. Receives Invitation to Give an Oral Presentation at The 29th International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2024)

Feb 9, 2024, 8:35 AM EST - 1 year ago

Top 5 Health Care Stocks That Are Preparing To Pump In February

CNSP GILD ZLAB

Feb 5, 2024, 4:41 PM EST - 1 year ago

Revelation Biosciences Inc. Announces Closing of $6.2 Million Public Offering

Feb 1, 2024, 6:00 AM EST - 1 year ago

Revelation Biosciences Inc. Announces Pricing of $6.2 Million Public Offering

Jan 30, 2024, 9:00 AM EST - 1 year ago

Revelation Biosciences Inc. to Present at The International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2024)

Jan 23, 2024, 9:00 AM EST - 1 year ago

Revelation Biosciences Inc. Announces 1-for-30 Reverse Stock Split Effective January 25, 2024

Nov 13, 2023, 4:05 PM EST - 1 year ago

Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2023

Oct 12, 2023, 9:00 AM EDT - 1 year ago

Gemini Induces Pharmacologic Activity and Related Physiologic Changes in Multiple Preclinical Studies

Oct 4, 2023, 9:00 AM EDT - 1 year ago

Revelation Biosciences, Inc. to Present at the 2023 ROTH Healthcare Opportunities Conference

Oct 2, 2023, 9:00 AM EDT - 1 year ago

Revelation Biosciences Inc. Announces Appointment of Lakhmir Chawla, M.D. to Board of Directors

Aug 11, 2023, 4:10 PM EDT - 2 years ago

Revelation Biosciences Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2023

Jun 29, 2023, 9:00 AM EDT - 2 years ago

REMINDER: Revelation Biosciences, Inc. Urges All Stockholders to Vote at the 2023 Annual Meeting of Stockholders

Jun 12, 2023, 4:15 PM EDT - 2 years ago

Revelation Biosciences Inc. Announces Adjournment of 2023 Annual Meeting of Stockholders to July 7, 2023 and Additional Proposal

May 22, 2023, 9:00 AM EDT - 2 years ago

Revelation Biosciences Inc. Announces Financial Results for the Three Months Ended March 31, 2023 and Recent Corporate Progress

Mar 30, 2023, 5:42 PM EDT - 2 years ago

Revelation Biosciences Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2022 and Recent Corporate Progress

Mar 13, 2023, 9:00 AM EDT - 2 years ago

Revelation Biosciences Inc. Appoints Dr. Julia Bohannon and Dr. Antonio Hernandez to Scientific Advisory Board

Mar 6, 2023, 9:00 AM EST - 2 years ago

Revelation Biosciences Inc. to Participate in a Fireside Chat at the 35th Annual Roth Conference

Feb 13, 2023, 4:20 PM EST - 2 years ago

Revelation Biosciences Inc. Announces Closing of $15.6 Million Public Offering

Feb 9, 2023, 9:42 AM EST - 2 years ago

Revelation Biosciences Inc. Announces Pricing of $15.6 Million Public Offering

Feb 7, 2023, 9:00 AM EST - 2 years ago

Revelation Biosciences Inc. Announces Preclinical Biomarker Data Supporting Activity of REVTx-300

Jan 31, 2023, 12:00 PM EST - 2 years ago

Revelation Biosciences Inc. Announces 1-for-35 Reverse Stock Split effective February 1, 2023 and Results of Special Meeting of Stockholders

Jan 10, 2023, 9:00 AM EST - 2 years ago

Revelation Biosciences Inc. Announces Mandatory Unit Separation to Occur on January 13, 2023

TheOldGeezer Jun. 16 at 5:31 PM

0 · Reply

Luvtoretire Jun. 16 at 4:48 PM

$SRM —Nice going bulls! $REVB —Lower float. Under 900k.

0 · Reply

lookgoodplaygood22 Jun. 15 at 1:44 AM

$REVB 50,000 shares. Sell set at $3. Set it and forget it.

1 · Reply

Extrawing22 Jun. 14 at 11:50 PM

$REVB Results are scheduled to be released before summer. It's likely this the week. Accumulating

1 · Reply

Fundy101 Jun. 13 at 2:39 PM

$REVB

0 · Reply

hassan101 Jun. 13 at 2:25 PM

$REVB Be ready.👌

0 · Reply

Luvtoretire Jun. 13 at 12:04 PM

$HUSA —Well done bulls! With half the float; $REVB —

0 · Reply

OrangeJoolius Jun. 12 at 6:16 PM

$REVB Added, this will at minimum go to 2 bucks when the data releases. Will buy more every time shorts attack it for stop losses.

0 · Reply

Locogomez Jun. 12 at 5:57 PM

$REVB New lows incoming…

0 · Reply

thaboss8854 Jun. 12 at 5:52 PM

$REVB patiently waiting for the topline data that will make the stock prices reach the top line.

0 · Reply

OrangeJoolius Jun. 11 at 7:34 PM

$REVB Bought back in yesterday, sellers look exhausted. Safe from dilution, splits and all that negative stuff. News coming in mid 2025 supposedly. Good place to get in IMO.

1 · Reply

D77727 Jun. 11 at 6:53 PM

$REVB boring😫

1 · Reply

CarlosRivera_ Jun. 11 at 6:46 PM

$JAGX walls getting cleared best to be early $NEGG $INM $WKHS $REVB ww

0 · Reply

TheOldGeezer Jun. 11 at 3:19 PM

$REVB Public float about 1 million shares - if results are good you might see 100 million shares traded in an hour - once it hits day trade scanners an Aaron Judge type 460 foot home run is likely.

1 · Reply

SkyLonger Jun. 11 at 3:14 PM

$REVB now if this one starts moving ⛱️🥂

0 · Reply

TheOldGeezer Jun. 11 at 2:35 PM

$REVB Added 1600 shares

0 · Reply

mc_101 Jun. 11 at 2:07 PM

$REVB uh oh!!!! My .79 is in danger. ⛔️ 🥵🥵🥵🥵🥵😅😅😥😥😥🤪🤪🤪😎😎😎

0 · Reply

OhNoTheSkyIsFalling Jun. 11 at 1:12 PM

$REVB Bears can shit on this all they want. Just completely ignoring forecasts, clinical trials are coming out any day to end of month and you can expect a 50%+ gain minimum for a swing.

0 · Reply

mc_101 Jun. 11 at 1:05 PM

$REVB 💩 💩 💩 🤪🤪🤪😎😎😎

0 · Reply

OhNoTheSkyIsFalling Jun. 11 at 12:59 PM

$REVB added some more at .818

0 · Reply

Guanabo498 Jun. 11 at 12:36 PM

$REVB

0 · Reply

Kz61544 Jun. 10 at 10:07 PM

$REVB not even 400k volume 😔

1 · Reply

Market Cap	765,000.00
Revenue (ttm)	0.00
Net Income (ttm)	-15.04M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	214,070
Avg Vol	1,239,162
Day's Range	N/A - N/A
Shares Out	964,000.00
Stochastic %K	6%
Beta	-0.09
Analysts	Strong Sell
Price Target	$20.73